"GlycoVision results featured at ESMO 2024: read the interview here to learn how InterVenn is powering new prognostic and predictive biomarkers!

Quality Policy

"InterVenn is driven by providing innovative products and solutions to our customers through our holistic understanding of glycoproteomics, other post-translational modifications, and health.

We are committed to set patient care at the core of everything we do, meet the needs of our employees, provide data integrity to scientists and clinicians, comply with regulatory requirements, engage in continuous improvement, and maintain an effective quality management system."

Get in touch